MSB 3.21% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-721

  1. 1,191 Posts.
    lightbulb Created with Sketch. 725
    It's a gamble - you know who else is gambling, the big pharma company that is paying Scott Lassman to create 'citizen petition' letters to the FDA re Rem-L
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.